Healthcare & Life Sciences M&A Insights
Value in HCLS hinges on reimbursement durability, quality systems, regulatory risk, and care delivery capacity. This hub curates Auxo’s analysis so operators and investors can focus on the levers that actually move multiples—and be diligence-ready.
What you’ll find here:
Looking for transaction support? See our
Healthcare & Life Sciences M&A Advisory Services
for sell-side, buy-side, and readiness work.
A buyer-underwriting guide to endoscopy center M&A, covering facility versus practice economics, acquirer fit, procedure contribution, usable capacity, physician ownership, clinical continuity, capital choices, and seller proceeds.
A sponsor-underwriting guide to private equity in gastroenterology, covering platform and add-on roles, earnings quality, regulated growth, financing, rollover governance, downside returns, and seller liquidity.
A buyer-landscape guide to gastroenterology practice acquirers, covering overlapping buyer models, platform examples, physician succession, facility interests, financing, integration, and offer certainty.
A seller-focused guide to selling a gastroenterology practice, covering physician and facility transferability, preparation, buyer qualification, LOIs, diligence, cash at close, and transition.
A transaction-focused guide to gastroenterology practice valuation multiples, connecting operating evidence, buyer underwriting, transaction risk, and seller outcomes.
A buyer-underwriting guide to gastroenterology practice valuation, connecting revenue quality, accepted EBITDA, endoscopy exposure, transaction structure, and seller proceeds.
A transaction-focused guide to gastroenterology practice M&A covering GI group economics, endoscopy exposure, buyer underwriting, diligence, financing, and seller outcomes.
A transaction-focused guide to vision care M&A, connecting optometry and ophthalmology revenue quality, optical retail, surgical exposure, referrals, payer mix, buyer underwriting, financing, and seller outcomes.
A buyer-underwriting guide to optometry practice valuation, including optical revenue, provider productivity, payer exposure, reported-to-normalized-to-buyer-accepted EBITDA, cash conversion, valuation methods, financing constraints, enterprise value, equity value, and seller proceeds.
A buyer-underwriting guide to eye-care valuation multiples, including accepted EBITDA, provider and optical economics, surgical exposure, payer and referral durability, capital intensity, acquirer demand, financing constraints, diligence sensitivity, and seller proceeds.